Binding characterization of the targeting drug AIMPILA to AFP receptors in human tumor xenografts
Open Access
- 9 October 2017
- journal article
- research article
- Published by IOS Press in Tumor Biology
- Vol. 39 (10)
- https://doi.org/10.1177/1010428317734815
Abstract
The main objective of this study was the characterization of preclinical tumor models based on their expression of alpha-fetoprotein receptor (RECAF) for targeting cancer cells with a new non-covalent complex (AIMPILA) containing alpha-fetoprotein as the carrier and Atractyloside as an apoptosis-inducing agent. For that purpose, we measured the amount of RECAF in the homogenates of the grafted tumors T47D and SW620 and in HepG2 cell extracts. We also determined the alpha-fetoprotein binding specificity of the targeting drug AIMPILA using a solid-phase chemiluminescent assay with AIMPILA-Acrdidinium. We found that RECAF is practically absent from healthy mice tissues (100 Units/mg) where in malignant cells, the amount of alpha-fetoprotein receptors follows this order: T47D (9152 Units/mg) > HepG2 (4865 Units/mg) > SW620 (2839 Units/mg). This agrees with our findings regarding AIMPILA-induced tumor growth inhibition (T47D (T/C = 22%) > HepG2 (T/C = 51%) > SW620 (T/C = 70%), where T/C is the ratio of tumor volume in treated vs control animals). Our results demonstrate that the therapeutic response to the targeting drug AIMPILA strongly depends on the RECAF expression by human tumors and confirms the choice of the tumor models used for an AIMPILA preclinical study.Keywords
This publication has 20 references indexed in Scilit:
- Increased Alpha-Fetoprotein Receptor in the Serum of Patients with Early-Stage Breast CancerCurrent Oncology, 2012
- Combination of CA125 and RECAF biomarkers for early detection of ovarian cancerTumor Biology, 2011
- Alpha fetoprotein is a novel protein‐binding partner for caspase‐3 and blocks the apoptotic signaling pathway in human hepatoma cellsInternational Journal of Cancer, 2009
- Alpha-Fetoprotein, Stem Cells and Cancer: How Study of the Production of Alpha-Fetoprotein during Chemical Hepatocarcinogenesis Led to Reaffirmation of the Stem Cell Theory of CancerTumor Biology, 2008
- Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cellsWorld Journal of Gastroenterology, 2004
- The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cellsCell Research, 2002
- Isolation and partial characterization of a specific alpha-fetoprotein receptor on human monocytes.JCI Insight, 1992
- Chemistry and Biology of α-FetoproteinPublished by Elsevier BV ,1991
- Expression of alpha-fetoprotein receptors by human T-lymphocytes during blastic transformationMolecular Immunology, 1989
- Alpha-Fetoprotein in Ontogenesis and its Association with Malignant TumorsPublished by Elsevier BV ,1971